Trade Alert: North Sea Energy And Biotech

Bullish options bets on one of last night's Top Names and a stock from our Multibaggers list.

Biotech And North Sea Energy

One of the advantages of having multiple idea sources is that we don’t have to force a trade from any single list.

Portfolio Armor’s Top Names are still the first place we look. Each trading day, our system uses price history and options market sentiment to estimate returns over the next six months for thousands of stocks and exchange traded products with options traded on them in the U.S. Since late 2022, we’ve been posting weekly Top Names cohorts on Substack and tracking how they did over the next six months versus SPY. You can see the running performance record here:

https://portfolioarmor.com/performance-top-names

That track record matters because it gives us a disciplined starting point.

Beyond Top Names

We also use our Market Watchers X list, Chartmill screens, technical filters, earnings/catalyst checks, and a smaller Multibaggers list.

For newer readers, Multibaggers are a handful of accounts from our Market Watchers X list with documented, recent 100%+ winners. They don’t replace Portfolio Armor’s Top Names, but they often surface less obvious names before they show up on more conventional screens.

Today’s alert has one trade from each bucket.

The Top Names trade is in a European energy major with North Sea exposure. The Multibaggers trade is an add-on biotech trade for us.

Different idea sources, same discipline: screen the name, check the theme, price the structure, and only swing when the risk/reward lines up.

North Sea Energy

The energy trade is straightforward.

If flows through the Strait of Hormuz take a while to return to prewar levels, oil and gas production outside the Gulf should remain attractive. North Sea production is not a perfect substitute for Gulf flows, but it is outside the choke point, politically stable, and strategically important to Europe.

That makes a North Sea-linked energy producer a useful place to look.

It’s not a moonshot trade. It’s a Top Names trade with a solid technical setup, a plausible macro tailwind, and an options chain that lets us build a defined-risk hybrid.

That’s enough.

Biotech Optionality

The biotech trade is more speculative.

We already have exposure to this name from an earlier trade, so today’s trade is an add-on, not a brand-new thesis. The reason it’s still interesting is that the setup has improved, the stock has elevated short interest, and one of our Multibaggers accounts remains excited about the underlying platform.

The near-term market angle is regulatory. The company has been through a difficult FDA process, but there may finally be some light at the end of that tunnel, thanks to significant turnover at the agency, replacing a coven of officials who deprioritized rare disease treatments. If sentiment shifts, there’s enough short interest here for the stock to move quickly.

The bigger idea is more interesting: the company’s platform may be part of the delivery infrastructure for future central nervous system therapeutics.

That’s the sort of bottleneck our Multibaggers source is focused on.

In biotech, the bottleneck is not always discovery. As AI accelerates target discovery and drug design, the harder question may become: how do you deliver the therapy safely, precisely, and in a regulated way?

That’s why platform companies can be interesting.

Owning The Bottlenecks

We’ve used a similar lens with Twist Bioscience (TWST 0.00%↑) , another biotech platform name we have an open trade in. Twist isn’t doing the same thing as today’s biotech name, but the platform logic is comparable: the appeal is not just one product, but the possibility that the platform becomes part of the enabling infrastructure for a broader wave of biotech development.

That’s the upside case here. It’s also why we don’t want to sell away all the upside too cheaply. The structure in today’s biotech trade lets us stay exposed to that possibility while keeping downside defined.

Two Trades, Same Process

So today’s alert has two trades:

One Top Names trade tied to North Sea energy and the possibility that Gulf energy flows take time to normalize.

One Multibaggers add-on trade in a biotech platform name with regulatory optionality, elevated short interest, and a potentially important role in CNS therapeutic delivery.

Different themes. Different sources. Same process.

Today’s Top Names Trade

European energy security / North Sea oil & gas theme